reported are certainly technically feasible during pregnancy and can be performed safely by those with sufficient skills and practice in the conduct of such procedures. A point that I hoped to make in my paper, and would like to reiterate here, was that my patients were selected for operation because they had severe symptoms or conditions that could have adversely affected the outcome of their pregnancies or placed the patients or their fetuses, or both, at risk for severe morbidity or even mortality without operation. I am still of the opinion that if symptoms are minimal, in nonappendicitis cases, it would be prudent to delay operation until the pregnancy has run its course, if such delay would not place the patient or fetus at risk. In gallbladder disease, the patient and her referring caregiver must be made aware of what signs and symptoms would alter the plan into a more rapid surgical intervention. One gallbladder attack or an episode of gallstone pancreatitis should prompt one into action, as these conditions can be highly unpredictable.
Similarly, if more rare conditions, such as diaphragmatic hernia or achalasia, are adversely affecting the course of a pregnancy, operation could be recommended in such patients, but if the conditions are coincidental and not a threat to the pregnancy and symptoms are minimal, I would favor delay until the pregnancy has concluded. Kerrey Buser, MD, FACS Plum Creek Surgery Clinic 1101 Buffalo Bend Lexington, NE 68850 USA
Re: JSLS. 2009;13:19-21 Laparoscopic Supracervical Hysterectomy for Benign Gynecological Conditions
We read with interest the paper by Hamilton B et al in your journal (JSLS 2009; 13:19-21 ). The author is to be commended for bravely supporting the argument for laparoscopic supracervical hysterectomy in spite of current evidence. In our center, we started with laparoscopicassisted vaginal hysterectomy (LAVH), but now we routinely perform total laparoscopic hysterectomy (TLH).
The authors say, ". . . both the ACOG and a recent Cochrane analysis clearly state that TAH is more beneficial than LSH in treating benign gynecological conditions." However, this statement is quite confusing, as the 
